subscribeSubscribe
Sentynl Acquires Zokinvy® For Progeria From Eiger Globally

Sentynl Acquires Zokinvy® For Progeria From Eiger Globally
PR NEWSWIRE
03 May 2024
Share Share
Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year

Eiger Files for Bankruptcy, Plans to Shutter Operations After Difficult Year
BIOSPACE
02 Apr 2024
Share Share
Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection

Eiger BioPharmaceuticals Files for Voluntary Chapter 11 Protection
GLOBENEWSWIRE
01 Apr 2024
Share Share
Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson

Eiger and Partner, AnGes, Receive Approval for Zokinvy) for Hutchinson
PR NEWSWIRE
18 Jan 2024
Share Share
EigerBio`s Zokinvy (lonafarnib) Receives Approval in Europe

EigerBio`s Zokinvy (lonafarnib) Receives Approval in Europe
EMA
24 Mar 2023
Share Share
Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib

Eiger to Host Conference to Discuss Phase 3 D-LIVR Study Results of Lonafarnib
PRNEWSWIRE
07 Dec 2022
Share Share
AnGes and Eiger collaborate to distribute Zokinvy in Japan

AnGes and Eiger collaborate to distribute Zokinvy in Japan
PHARMACEUTICAL-TECHNOLOGY
11 May 2022
Share Share
Eiger concludes subject enrolment in Phase III HDV drug trial

Eiger concludes subject enrolment in Phase III HDV drug trial
CLINICALTRIALSARENA
01 Nov 2021
Share Share
Eiger BioPharmaceuticals Receives Rare Impact Award for Innovation from the NORD

Eiger BioPharmaceuticals Receives Rare Impact Award for Innovation from the NORD
PR NEWSWIRE
29 Jun 2021
Share Share
The top 20 most expensive pharmacy drugs in the U.S. in 2021

The top 20 most expensive pharmacy drugs in the U.S. in 2021
Angus Liu FIERCEPHARMA
09 Mar 2021
Share Share